Verrica Pharmaceuticals Inc (VRCA)
6.76
-0.09
(-1.31%)
USD |
NASDAQ |
May 02, 16:00
6.78
+0.02
(+0.30%)
After-Hours: 20:00
Verrica Pharmaceuticals Debt to Equity Ratio: 2.169 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.169 |
| September 30, 2023 | 1.002 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | 2.589 |
| March 31, 2022 | 1.652 |
| December 31, 2021 | 1.279 |
| September 30, 2021 | 1.012 |
| June 30, 2021 | 0.7862 |
| March 31, 2021 | 0.658 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2022
2.589
Maximum
Jun 2022
0.929
Average
0.8942
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.60M |
| Total Liabilities (Quarterly) | 61.83M |
| Shareholders Equity (Quarterly) | 19.76M |
| Current Ratio | 4.554 |
| Net Debt Paydown Yield | -2.76% |